Skip to content

Whole-Exome Sequencing in Dutch Children with Primary Sclerosing Cholangitis (WHELP-study)

Whole-Exome Sequencing in Dutch Children with Primary Scleorsing Cholangitis (WHELP-study)

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
NL-OMON
Registry ID
NL-OMON21047
Enrollment
50
Registered
2017-02-13
Start date
2017-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary sclerosing cholangitis, Whole-Exome Sequencing, Primaire scleroserende cholangitis, Inflammatory Bowel Disease

Interventions

Between January 2017 and July 2017 we hope to collect blood from 50 small pedigrees. We will analyse the genotypes of each included family to look for markers or intervals that show perfect segregatio

Sponsors

University Medical Center Groningen (UMCG), Department of Pediatric Gastroenterology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: This family based study involves two groups of participants: (1) The index patient who developed PSC before the age of 13, and in whom PSC was confirmed with either cholangiography or liver biopsy, and (2) The biological parents. Eligible candidates of group 1 can have any age. Confirmation of PSC by imaging is defined as the presence of multifocal strictures, focal dilatation, or beading of the biliary tree. Histological confirmation is defined as the presence of bile duct damage, onion-skinned peri-ductal fibrosis, inflammation, portal edema or fibrosis, ductopenia, ductular proliferation, or cholestasis.

Exclusion criteria

Exclusion criteria: Patients with PSC due to secondary causes such as surgery, trauma, cancer or infection will be excluded from participation in this study.

Design outcomes

Primary

MeasureTime frame
The identification of rare monogenic forms of PSC.

Secondary

MeasureTime frame
Not applicable.

Contacts

Public ContactP.F. Rheenen, van

Brinklaan 6

p.f.vanrheenen@gmail.com

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)